Sage Journals: Discover world-class research

Retricted access

Case report

First published 2019-7

Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapy

Tyler Beardslee, Amber Draper, Ragini Kudchadkar

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2018-6

The adverse kidney effects of cancer immunotherapies

Danielle L Saly, Mark A Perazella

Journal of Onco-Nephrology

Retricted access

Case report

First published 2022-4

Use of Cystatin C to Assess Immunotherapy Toxicity in a Patient With Melanoma

Dylan M. Barth, Danielle Otto, Peng Wang [...]

Journal of Pharmacy Practice

Open access

Research article

First published 2019-06

Immunotherapy-Related Adverse Effects When Treating Cancer #375

Christina Matts, Anna Beck

Journal of Palliative Medicine

Retricted access

Case report

First published 2021-10

Avoiding immunogenic drugs is key to preserve renal function in patients receiving immune checkpoint inhibitors: Lessons learned from three illustrative cases

Laura Martínez Valenzuela, Paula Antón, Ariel Tango [...]

Journal of Onco-Nephrology

Retricted access

Research article

First published 2025-6

Immune-related adverse effects: Recognition and initiation of appropriate treatment in cancer patients on immunotherapy

Riley Mohr, Anna Howard, Melanie Townsend

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2025-10

Evaluation of safety outcomes between nivolumab regimens with differing dosing patterns

Joseph Elijah, Igor Puzanov, Benjamin Cresanti [...]

Journal of Oncology Pharmacy Practice

Retricted access

Letter

First published 2022-3

Skindex-Mini Among Patients With Melanoma Who Have Cutaneous Immunotherapy-Related Adverse Effects

Howa Yeung, Krittin J. Supapannachart, Emily F. Cole [...]

Journal of Cutaneous Medicine and Surgery

Retricted access

Brief report

First published 2016-5-10

Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer’s Disease: Need for Prognostic Biomarkers?

Fabrizio Piazza, Bengt Winblad

Journal of Alzheimer’s Disease

Retricted access

Research article

First published 2026-3

Dinutuximab-Associated Neurotoxicity: Incidence,Presentation,Risk Factors,and Nursing Interventions

Kristen L. Dalton, Erin A. Armideo, Shannon L. Markert [...]

Journal of Pediatric Hematology/Oncology Nursing

Search results